Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort.
Dig Dis Sci. 2022 Mar;67(3):1007-1017. doi: 10.1007/s10620-021-06907-5. Epub 2021 Mar 9.
Dig Dis Sci. 2022.
PMID: 33751325
Free PMC article.
The IBD-F Patient Self-Assessment Scale Accurately Depicts the Level of Fatigue and Predicts a Negative Effect on the Quality of Life of Patients With IBD in Clinical Remission.
Varbobitis I, Kokkotis G, Gizis M, Perlepe N, Laoudi E, Bletsa M, Bekiari D, Koutsounas I, Kounadis G, Xourafas V, Lagou S, Kolios G, Papakonstantinou I, Bamias G.
Varbobitis I, et al. Among authors: xourafas v.
Inflamm Bowel Dis. 2021 May 17;27(6):826-835. doi: 10.1093/ibd/izaa201.
Inflamm Bowel Dis. 2021.
PMID: 32766770
Item in Clipboard
Response to Anti-α4β7 Blockade in Patients With Ulcerative Colitis Is Associated With Distinct Mucosal Gene Expression Profiles at Baseline.
Gazouli M, Dovrolis N, Bourdakou MM, Gizis M, Kokkotis G, Kolios G, Michalopoulos G, Michopoulos S, Papaconstantinou I, Tzouvala M, Viazis N, Xourafas V, Zacharopoulou E, Zampeli E, Mantzaris G, Papatheodoridis G, Bamias G.
Gazouli M, et al. Among authors: xourafas v.
Inflamm Bowel Dis. 2022 Jan 5;28(1):87-95. doi: 10.1093/ibd/izab117.
Inflamm Bowel Dis. 2022.
PMID: 34042157
Item in Clipboard
Correction: DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis B.
Papatheodoridis GV, Rigopoulou EI, Papatheodoridi M, Zachou K, Xourafas V, Gatselis N, Hadziyannis E, Vlachogiannakos J, Manolakopoulos S, Dalekos GN.
Papatheodoridis GV, et al. Among authors: xourafas v.
Antivir Ther. 2018;23(8):711. doi: 10.3851/IMP3261.
Antivir Ther. 2018.
PMID: 30091421
No abstract available.
Item in Clipboard
DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis B.
Papatheodoridis GV, Rigopoulou EI, Papatheodoridi M, Zachou K, Xourafas V, Gatselis N, Hadziyannis E, Vlachogiannakos J, Manolakopoulos S, Dalekos GN.
Papatheodoridis GV, et al. Among authors: xourafas v.
Antivir Ther. 2018;23(8):677-685. doi: 10.3851/IMP3256.
Antivir Ther. 2018.
PMID: 30044765
Item in Clipboard
Autoantibodies in type 1 diabetes.
Heras P, Mantzioros M, Mendrinos D, Heras V, Hatzopoulos A, Xourafas V, Kritikos K, Karagiannis S.
Heras P, et al. Among authors: xourafas v.
Diabetes Res Clin Pract. 2010 Nov;90(2):e40-2. doi: 10.1016/j.diabres.2010.08.015. Epub 2010 Sep 15.
Diabetes Res Clin Pract. 2010.
PMID: 20833441
Item in Clipboard
Efficacy and safety of capecitabine and oxaliplatin combination as second-line treatment in advanced colorectal cancer.
Heras P, Kritikos K, Hatzopoulos A, Xourafas V, Kritikos N, Karagiannis S, Mitsibounas D.
Heras P, et al. Among authors: xourafas v.
Am J Ther. 2009 Jul-Aug;16(4):319-22. doi: 10.1097/MJT.0b013e31819607e0.
Am J Ther. 2009.
PMID: 19352139
Item in Clipboard
Cite
Cite